At Tactile Medical, a fundamental value is to earn a fair profit and return value for our shareholders
--
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Upcoming Events
More events are coming soon.
Recent News
-
October 2, 2024
Tactile Medical Launches Next-Generation Nimbl™ Lymphedema Platform
Read moreInitial Launch Focused on Treating Patients Suffering from Upper Extremity Lymphedema MINNEAPOLIS , Oct. 02, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic
-
September 25, 2024
Tactile Medical Announces Positive Clinical Trial Results in Lymphedema Patients Using Advanced Pneumatic Compression Device Therapy
Read moreLargest U.S. Prospective Clinical Trial Ever Conducted Demonstrated High Compliance with the Flexitouch® System and Significant Improvements Across Study Endpoints MINNEAPOLIS , Sept. 25, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a
-
September 16, 2024
Tactile Medical Receives PDAC Approval for Nimbl™ Lymphedema Platform
Read moreNext-Generation System Significantly Reduces Device Size and Weight and Enables Integration with Kylee™ Digital App MINNEAPOLIS , Sept. 16, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies